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This study, carried out in a low tuberculosis (TB) preva-
lence country with high immigration rates from high TB 
prevalence countries, deals with the interferon-gamma 
release assay, QuantiFERON®-TB Gold In-Tube, for the 
diagnosis of latent TB infection (LTBI) in foreign-born 
children. The results of our study highlight the poten-
tial advantages and concerns of using a blood test for 
diagnosing LTBI in a ‘two-step’ strategy in foreign-born 
children.
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OVER THE LAST 30 YEARS, industrialised coun-
tries have witnessed a progressive increase in tuber-
culosis (TB) incidence, partly related to the growing 
number of immigrants from high TB incidence areas. 
Accurate diagnosis of latent TB infection (LTBI) cases 
is a desirable goal in achieving effective TB control in 
low-incidence countries, particularly in young chil-
dren, who are more prone to severe disease as a con-
sequence of recent infection and in whom preventive 
chemotherapy is effective and relatively safe.1,2 
Until recently, LTBI detection relied only on the tu-
berculin skin test (TST), known to be associated with 
false-positive results in children infected with non-
t uberculous mycobacteria (NTM) or bacille Calmette-
Guerin (BCG) vaccinated, as is the case with the ma-
jority of the children born in high TB incidence 
countries.3,4 Furthermore, TST sensitivity may be 
impaired in young children, and in several other con-
ditions such as immunosuppression.5,6 The positive 
cut-off of the TST indura-tion therefore depends on 
the likelihood of infection and on the individual risk 
of developing active TB.6,7 Interferon-gamma release 
assays (IGRAs) represent an attractive tool for TB 
screening due to their high diagnostic accuracy, al-
though their performance in paediatric subjects needs 
corroborating evidence. 
Policies for TB screening in immigrant children 
vary widely across Europe.8 For immigrants from TB-
endemic countries, the current Italian national guide-
lines set the cut-off for a positive TST at 10 mm, re-
gardless of age and BCG vaccination status.
Given the increasing numbers of active TB cases 
among children and adolescents in recent years in our 
region, in late 2005 the community paediatrics unit 
of the local health service in Modena implemented 
testing with the QuantiFERON®-TB Gold In-Tube 
assay (QFT; Cellestis Ltd, Carnegie, VIC, Australia) 
of all children with both positive (⩾10 mm) and bor-
derline (5–9 mm) TST (5 units of purifi ed protein de-
rivative, Biocine Test PPD, Chiron, Siena, Italy).9 Sam-
ples for IGRA testing were processed a ccording to the 
manufacturer’s instructions. In the present study, we 
report data on a group of immigrant children evalu-
ated between January 2006 and December 2008.
RESULTS
We performed 621 TSTs in children and adolescent 
immigrants, mostly from Africa (40.3%) and Eastern 
Europe (26.9%): 104 (16.7%) were TST-positive, 
128 (20.6%) were TST-borderline and 389 (62.6%) 
TST-negative. Children in the fi rst two groups were 
tested with QFT at 31 ± 29 days (mean ± standard 
deviation) after TST. Three children had an invalid 
QFT result and were excluded from further analyses. 
QFT was positive in 80 (34.5%) children: 30 had 
borderline TST (30/125, 24%) and 50 were TST-pos-
itive (50/104, 48.1%; Figure 1). By logistic regression 
analysis, a positive correlation was found between a 
positive QFT and the size of TST induration (odds 
ratio [OR] 1.23, 95% confi dence interval [CI] 1.12–
1.36, P < 0.001). 
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The distribution of TST and QFT results accord-
ing to age is shown in Figure 2. TST-positive, QFT-
negative results diminish with increasing age (OR 
0.88, 95%CI 0.82–0.95, P = 0.001), while TST-
b orderline, QFT-positive results are not related to age 
(OR 1.04, 95%CI 0.94–1.15, P = 0.458). All QFT-
negative, TST-positive tests had interferon-gamma 
(IFN-γ) levels <0.20 international units (IU)/ml, while 
the majority (n = 26) of the 30 QFT-positive children 
with borderline TST had IFN-γ levels > 0.50 IU/ml.
All children were healthy on clinical examination 
and none complained of respiratory symptoms. Never-
theless, four TST-positive, QFT-positive children had 
radiological fi ndings consistent with active TB, con-
fi rmed by microbiological culture (acid-fast bacilli 
smear-negative). These TB cases were aged >10 years 
and BCG-vaccinated: TST size and IFN-γ levels were 
respectively 12 mm/17.0 IU, 13 mm/15.9 IU, 11 mm/ 
16.2 IU and 10 mm/9.4 IU. Isoniazid (INH) was of-
fered to all QFT-positive children (n = 76), with the 
exception of two children with coexisting chronic 
liver disease. Based on clinical judgment, children 
aged <8 years with TST > 15 mm (n = 3) were also 
treated with INH, as were those subjects for whom 
reliable follow-up could not be guaranteed (n = 4). 
For TST-positive, QFT-negative children, paediatri-
cians were advised to provide strict follow-up; at the 
time of writing, no additional cases of active TB have 
been notifi ed in this group.
DISCUSSION
Using blood tests to diagnose LTBI in immigrant chil-
dren permits the diagnosis of infection in a sizeable 
fraction of children with TST results between 5 and 
9 mm: we report here that about one third of these 
children were QFT-positive, usually with high IFN-γ  
levels. Although longitudinal data in children are not 
yet available, it is currently assumed that individuals 
with TST induration between 5 and 9 mm and a pos-
itive QFT are likely to be infected with Mycobacte-
rium tuberculosis.10 Based on this assumption, we of-
fered treatment to all of these children. Assuming that 
children with a positive QFT are truly infected and 
that those with a negative TST are non-infected, LTBI 
Figure 1 Flow chart of the study. TST = tuberculin skin test; 
BCG = bacille Calmette-Guérin; QFT = QuantiFERON®-TB Gold 
In-Tube.
Figure 2 Distribution of QFT results by TST result and age group. TST = tuberculin skin test; 
QFT = QuantiFERON®-TB Gold In-Tube.
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prevalence in this group could be estimated to be 
around 13%. A limitation of this study is that TST-
negative children did not undergo QFT testing, and 
we cannot exclude that some of them might also be 
infected.
As previously reported, only half of the children 
with a positive TST were QFT-positive. Both BCG 
vaccination and exposure to NTM might help in in-
terpreting some of these TST results as falsely posi-
tive; recent longitudinal data in household contacts 
would support this concept.11 Active pulmonary TB 
was diagnosed in four BCG-vaccinated, asymptom-
atic adolescents: all were positive on both QFT (at 
high IFN-γ levels) and TST (>10 mm). These fi nd-
ings confi rm recent data obtained in the context of 
contact screening showing that quantitative results of 
both TST and IGRA may assist in the identifi cation 
of subjects with active disease.12,13 A combination of 
a TST > 10 mm and high QFT levels might also help 
to identify children with active disease in the context 
of screening programmes.
BCG vaccination is usually given in the fi rst days 
of life, and its effect on TST is presumed to be stron-
gest in the fi rst 10–15 years.4 On the other hand, 
younger children are more prone to developing severe 
disease. As the sensitivity of IGRA in young children 
has not yet been proven, the decision to disregard a 
positive TST because of a negative QFT is debatable, 
and caution should be used in this regard. It is there-
fore crucial to emphasise the importance of parental 
education regarding symptoms of TB. Consistent clini-
cal follow-up to monitor for disease progression in 
young children should be in place, particularly con-
sidering the poor (TST) or still unproven (IGRA) sen-
sitivity of diagnostic tests in this population group. 
Last, our data indicate that clinicians must always 
consider age and risk of disease progression when de-
ciding whether to disregard a positive TST in young 
immigrant children.
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Notre étude, menée dans un pays à faible prévalence de 
la tuberculose (TB) avec des taux d’immigration élevés 
provenant de pays à haute prévalence de la TB, traite du 
test de libération de l’interféron-gamma, Quanti FERON®-
TB Gold In-Tube pour le diagnostic de l’in fection tuber-
culeuse latente (LTBI) chez les enfants nés à l’étranger. 
Les résultats de notre étude illustrent les avantages po-
tentiels et les préoccupations concernant l’utilisation 
d’un test sanguin pour le diagnostic d’une LTBI dans 
une stratégie en deux étapes concernant les enfants nés à 
l’étranger. 
El presente estudio se llevó a cabo en un país de baja 
prevalencia de tuberculosis con un alto nivel de inmi-
gración procedente de países con tasas altas de preva-
lencia de esta enfermedad; se analizó el rendimiento de 
la prueba de liberación de interferón gama, Quanti-
FERON®-TB Gold En Tubo, en el diagnóstico de la in-
fección tuberculosa latente (LTBI) en los niños nacidos 
en el extranjero. Los resultados destacan las posibles 
ventajas y las difi cultades del uso de una prueba san-
guínea para establecer el diagnóstico de LTBI en los 
n iños nacidos en el extranjero, mediante una estrategia 
en dos etapas.
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